Efficacy of Dexamethasone Added to Ramosetron for Preventing Postoperative Nausea and Vomiting in Highly Susceptible Patients Following Spine Surgery

• Status: Completed
• Trial end date: 2008-11-01
• Target enrollment: 0
• Participant gender: Female

Summary

The purpose of this study is to study the efficacy of dexamethasone added to ramosetron for preventing postoperative nausea and vomiting in highly susceptible patients following spine surgery.

• Phase: Phase 4
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Yonsei University
• Treatments: BB 1101; Dexamethasone; Dexamethasone 21-phosphate; Dexamethasone acetate; Ramosetron

Criteria

Inclusion Criteria:

• Females

• Ages 18 to 65 years old

Exclusion Criteria:

• Patients who is taking steroid or who had been treated for the gastrointestinal disease

• Patients who have troubles with the kidney or liver

• Patients transferring to the ICU after the surgery

• overfat patients

• Patients who had taken antiemetics within 24 hours before the surgery